MIR31HG knockdown enhanced the expression of MMPs, including MMP1 and MMP3, suggesting that MIR31HG, is a positive downstream regulator of tocilizumab and may mitigate pathological features of RA by inhibiting the invasiveness of RA-FLS. This evidence concerns the gene MMP3 and rheumatoid arthritis.